Contact Us
  Search
The Business Research Company Logo
Global Pediatric Heart Valve Repair And Replacement Market Report 2026
Published :January 2026
Pages :150
Format :PDF
Delivery Time :2-3 Business Days
Why 2-3 days? We update the report with the latest data and news before delivery. Let us know if you need us to expedite.
Report Price :$4,490.00

Pediatric Heart Valve Repair And Replacement Market Report 2026

Global Outlook – By Product (Heart Valve Repair, Mechanical Heart Valves, Bioprosthetic Heart Valves, Transcatheter Aortic Valve Implantation (TAVI)), By Indication (Congenital Heart Defects, Heart Muscle Disease, Atresia, Arrhythmias, Other Cardiac Disorders), By End-User (Hospitals, Independent Cardiac Catheterization Labs, Ambulatory Surgical Centers) – Market Size, Trends, Strategies, and Forecast to 2035

Pediatric Heart Valve Repair And Replacement Market Overview

• Pediatric Heart Valve Repair And Replacement market size has reached to $3.47 billion in 2025 • Expected to grow to $3.97 billion in 2030 at a compound annual growth rate (CAGR) of 2.8% • Growth Driver: The Rising Incidence Of Congenital Heart Defects Fuels Growth In The Pediatric Heart Valve Repair And Replacement Market • Market Trend: Strategic Partnerships Drive Innovation In Pediatric Heart Valve Repair And Replacement Industry • North America was the largest region in 2025.
Research Expert

Book your 30 minutes free consultation with our research experts

What Is Covered Under Pediatric Heart Valve Repair And Replacement Market?

Pediatric heart valve repair and replacement refers to the medical procedures and technologies used to address heart valve issues in children. These procedures aim to treat congenital or acquired heart valve disorders in children, often necessitated by conditions such as congenital heart defects, heart muscle disease, arrhythmias, and atresia. The main types of products in pediatric heart valve repair and replacement are heart valve repair, mechanical heart valves, bioprosthetic heart valves, and transcatheter aortic valve implantation (TAVI). Heart valve repair refers to a medical procedure aimed at restoring the normal function of a malfunctioning heart valve. And it includes several indications, such as congenital heart defects, heart muscle disease, atresia, arrhythmias, and other cardiac disorders, and end users are hospitals, independent cardiac catheterization labs, and ambulatory surgical centers.
Pediatric Heart Valve Repair And Replacement market report bar graph

What Is The Pediatric Heart Valve Repair And Replacement Market Size and Share 2026?

The pediatric heart valve repair and replacement market size has grown steadily in recent years. It will grow from $3.47 billion in 2025 to $3.56 billion in 2026 at a compound annual growth rate (CAGR) of 2.8%. The growth in the historic period can be attributed to rising burden of congenital heart defects in neonatal and pediatric populations, growing availability of surgical heart valve repair techniques, increasing pediatric cardiac surgeries in hospital-based cath labs, early clinical adoption of mechanical and bioprosthetic pediatric valves, expansion of specialized pediatric cardiology and cardiac surgery centers.

What Is The Pediatric Heart Valve Repair And Replacement Market Growth Forecast?

The pediatric heart valve repair and replacement market size is expected to see steady growth in the next few years. It will grow to $3.97 billion in 2030 at a compound annual growth rate (CAGR) of 2.8%. The growth in the forecast period can be attributed to increasing demand for minimally invasive and transcatheter pediatric valve interventions, rising focus on long-term valve performance and reintervention reduction, growing treatment volumes across atresia and arrhythmia indications, expanding access to pediatric cardiac care in emerging regions, increasing investment in pediatric-specific heart valve design and durability research. Major trends in the forecast period include rising adoption of pediatric heart valve repair procedures for congenital cardiac disorders, increasing utilization of mechanical and bioprosthetic valves in pediatric valve replacement, growing preference for minimally invasive and catheter-based valve repair techniques, expansion of tavi-based interventions in complex pediatric valve conditions, increasing clinical focus on long-term durability and growth-compatible pediatric valve solutions.

Global Pediatric Heart Valve Repair And Replacement Market Segmentation

1) By Product: Heart Valve Repair, Mechanical Heart Valves, Bioprosthetic Heart Valves, Transcatheter Aortic Valve Implantation (TAVI) 2) By Indication: Congenital Heart Defects, Heart Muscle Disease, Atresia, Arrhythmias, Other Cardiac Disorders 3) By End-User: Hospitals, Independent Cardiac Catheterization Labs, Ambulatory Surgical Centers Subsegments: 1) By Heart Valve Repair: Surgical Repair Techniques, Catheter-Based Repair Techniques 2) By Mechanical Heart Valves: Tilting Disc Valves, Bileaflet Valves, Other Mechanical Valves 3) By Bioprosthetic Heart Valves: Porcine Valves, Bovine Valves, Other Bioprosthetic Valves 4) By Transcatheter Aortic Valve Implantation (TAVI): Balloon-Expandable Valves, Self-Expanding Valves, Other TAVI Devices

What Is The Driver Of The Pediatric Heart Valve Repair And Replacement Market?

The increasing incidence of congenital heart defects is expected to propel the growth of the pediatric heart valve repair and replacement market going forward. A congenital heart defect (CHD) is a problem with the structure of the heart that is present at birth. Pediatric heart valve repair and replacement are used in the treatment of congenital heart defects to improve the heart's function and the child's overall health, prevent complications, and improve the quality of life for affected children. For instance, in October 2024, according to reports published by the Centers for Disease Control and Prevention, a US-based national public health agency, heart defects affect nearly 1% of?or about 40,000?births per year in the United States. About 1 in 4 babies with a heart defect have a critical heart defect. For every 15 minutes, a baby born with a heart defect in America in 2023. Therefore, the increasing incidence of congenital heart defects will drive concrete restoration market growth.

Key Players In The Global Pediatric Heart Valve Repair And Replacement Market

Major companies operating in the pediatric heart valve repair and replacement market are Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, Lepu Medical Technology (Beijing) Co. Ltd., Edwards Lifesciences Corporation, Artivion Inc., CryoLife Inc., LivaNova PLC, TTK Healthcare Limited, Braile Biomedica Ltda., Micro Interventional Devices Inc., Xeltis AG, Auto Tissue Berlin GmbH, BioStable Science and Engineering Inc., Colibri Heart Valve LLC, Valcare Medical, Symetis SA, On-X Life Technologies Holdings Inc., JenaValve Technology Inc., Meril Life Sciences Pvt. Ltd.

What Are Latest Mergers And Acquisitions In The Pediatric Heart Valve Repair And Replacement Market?

In July 2024, Edwards Lifesciences, a US-based medical technology company, acquired Innovalve Bio Medical Ltd., for an undisclosed amount. This acquisition aims to strengthens the company’s transcatheter mitral valve replacement (TMVR) technologies to meet significant unmet needs in structural heart patients and contribute to sustainable long-term growth. Innovalve Bio Medical Ltd. is an Israel-based developer of TMVR technology and cardio valves.

Need data on a specific region in this market?

Regional Outlook

North America was the largest region in the pediatric heart valve repair and replacement market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Pediatric Heart Valve Repair And Replacement Market?

The pediatric heart valve repair and replacement market includes revenues earned by providing services such as diagnosis and evaluation, treatment planning, medical management, surgical intervention and surgery. The market value includes the value of related goods sold by the service provider or included within the service offering. The pediatric heart valve repair and replacement market also consists of sales of biological valves, postoperative monitoring devices, sutures and repair materials, annuloplasty rings and bands, and annuloplasty rings and bands. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Pediatric Heart Valve Repair And Replacement Market Report Forecast Analysis

Report Attribute Details
Market Size Value In 2026$3.56 billion
Revenue Forecast In 2035$3.97 billion
Growth RateCAGR of 2.8% from 2026 to 2035
Base Year For Estimation2025
Actual Estimates/Historical Data2020-2025
Forecast Period2026 - 2030 - 2035
Market RepresentationRevenue in USD Billion and CAGR from 2026 to 2035
Segments CoveredProduct, Indication, End-User
Regional ScopeAsia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country ScopeThe countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies ProfiledAbbott Laboratories, Medtronic plc, Boston Scientific Corporation, Lepu Medical Technology (Beijing) Co. Ltd., Edwards Lifesciences Corporation, Artivion Inc., CryoLife Inc., LivaNova PLC, TTK Healthcare Limited, Braile Biomedica Ltda., Micro Interventional Devices Inc., Xeltis AG, Auto Tissue Berlin GmbH, BioStable Science and Engineering Inc., Colibri Heart Valve LLC, Valcare Medical, Symetis SA, On-X Life Technologies Holdings Inc., JenaValve Technology Inc., Meril Life Sciences Pvt. Ltd.
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options
Chat with us